Literature DB >> 56971

e antigen in acute hepatitis B.

G Norkrans, L Magnius, S Iwarson.   

Abstract

To examine the association between e antigen and hepatitis-B surface antigen (HBs Ag) we studied 90 inpatients with acute viral hepatitis type B. e Antigen was present in 24 of the patients; these patients had detectable levels of HBs Ag for significantly longer than the 66 with no e antigen in their serum. The HBs Ag subtypes D (adw) and Y (ayw) were similarly distributed among patients with e antigen and among those without, and no differences in the results of biochemical liver function tests were observed between the two groups during the acute phase of illness. Three of the five patients who developed clinical and histological signs of chronic liver disease were positive for e antigen, a finding which supports the hypothesis that e antigen has a prognostic value in hepatitis B.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 56971      PMCID: PMC1639162          DOI: 10.1136/bmj.1.6012.740

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

1.  [Carriers of hepatitis B antigen and infectivity].

Authors:  E Nordenfelt
Journal:  Lakartidningen       Date:  1975-09-10

2.  Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme.

Authors:  J O Nielsen; O Dietrichson; E Juhl
Journal:  Lancet       Date:  1974-10-19       Impact factor: 79.321

3.  New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

Authors:  L O Magnius; J A Espmark
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

4.  Morphological criteria in viral hepatitis. Review by an international group.

Authors: 
Journal:  Lancet       Date:  1971-02-13       Impact factor: 79.321

5.  [Ultrastructural study of "Australia" antigen. 1. Morphological diversity of Australia antigen].

Authors:  O Couleru; R Moulias; F Peter; O Bousquet; A German; J Loeper
Journal:  Nouv Presse Med       Date:  1973-06-16

6.  Differential distribution of Australia-antigen-associated particles in patients with liver diseases and normal carriers.

Authors:  J O Nielsen; M H Nielsen; P Elling
Journal:  N Engl J Med       Date:  1973-03-08       Impact factor: 91.245

7.  Characterization of a new antigen-antibody system associated with hepatitis B.

Authors:  L O Magnius
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

8.  e Antigen-antibody system as indicator of liver damage in patients with hepatitis-B antigen.

Authors:  N El Sheikh; I L Woolf; R M Galbraith; A L Eddleston; I W Dymock; R Williams
Journal:  Br Med J       Date:  1975-11-01
  8 in total
  8 in total

1.  HBsAg subtype distribution among different populations of HBsAg carriers in Spain.

Authors:  J E Echevarría; P León; J A López; A Tenorio; C J Domingo; J M Echevarría
Journal:  Eur J Epidemiol       Date:  1995-02       Impact factor: 8.082

2.  Persistence of e antigen as prognostic marker in acute hepatitis B.

Authors:  G Pastore; P Dentico; G Angarano; E Lapedota; O Schiraldi
Journal:  Infection       Date:  1979       Impact factor: 3.553

3.  Occurrence of e antigen in acute hepatitis B.

Authors:  P E Gibson; K Ruparella
Journal:  J Clin Pathol       Date:  1977-10       Impact factor: 3.411

4.  Incidence and clinical significance of HBe antigen and antibody in HBsAg-positive various liver diseases.

Authors:  S Fujiyama; K Sagara; J Takano; D Iwaoka; T Deguchi; K Mizuno; N Ohtomo
Journal:  Gastroenterol Jpn       Date:  1979-12

5.  e Antigen and antibody in outbreaks of hepatitis B in two renal dialysis units.

Authors:  P E Gibson
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

6.  Hepatitis B e-antigen titres for evaluating infectivity during hepatitis B virus infection.

Authors:  E G Lindenschmidt; C F Granato; C Salefsky; R Laufs; H Henning
Journal:  Klin Wochenschr       Date:  1984-03-01

7.  Changes in hepatitis B virus DNA polymerase in relation to the outcome of acute hepatitis type B.

Authors:  A Alberti; S Diana; A L Eddleston; R Williams
Journal:  Gut       Date:  1979-03       Impact factor: 23.059

8.  Liver disease and the e antigen in HBsAg carriers with chronic renal failure.

Authors:  G P Coughlin; A G Van Deth; A P Disney; J Hay; A G Wangel
Journal:  Gut       Date:  1980-02       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.